Of the patients, 13 out of 39 patients (33.3%) satisfied the criteria for MetS+, 19 out of 39 individuals (48.7%) were insulin resistant, 28 out 39 (71.8%) had hypertension, 7 out of 39 (18%) were obese, and 15 out of 39 (38.5%) were overweight. This evidence concerns the gene INS and metabolic syndrome.